Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Imcivree, known by its generic name Setmelanotide, is a medication classified as a melanocortin 4 receptor agonist. By activating these receptors, Imcivree may help reduce hunger and promote weight loss. For this reason, it is used to treat certain genetic obesity disorders resulting from gene mutations. Healthcare professionals typically prescribe it to both adults and children (ages 6 and older) who are living with conditions like proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiencies.
Imcivree is administered via a subcutaneous injection, meaning the medicine is injected under the skin. The typical recommended dosage is 3 mg once daily for people 6 years and older. However, the starting dosage may be lower and depend on the age of the person taking it.
Individuals with mild to moderate kidney problems do not require dosage adjustments. However, for people with severe renal impairment, medical professionals may recommend changes to the dosing schedule. Consult a healthcare provider for the proper dosage and instructions for using the medication.
The active ingredient in Imcivree is Setmelanotide. The medication may also contain inactive ingredients, such as mannitol, phenol, benzyl alcohol, and water for injection.
People with a known allergy or hypersensitivity to Setmelanotide or any ingredients of the medication should avoid taking it.
Imcivree carries a risk of side effects, with some being more common than others. Among the most common Imcivree side effects, people may experience injection site reactions, with symptoms like pain or irritation around the area of injection. Skin darkening or hyperpigmentation is also frequently observed. Some people report feelings of nausea, headaches, diarrhea, stomach pain, back pain, fatigue, and occasional vomiting.
While most side effects are manageable, Imcivree may also cause more serious side effects. These may include depression, prolonged erections, and severe allergic reactions, which might cause rash, hives, or breathing difficulties. If any serious side effects occur, seek medical attention.